Liquidia share price today

(LQDA)

Liquidia share price is $11.53 & ₹982.33 as on 25 Dec 2024, 2.30 'hrs' IST

$11.53

▲

0.09

(0.79%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Liquidia share price in Dollar and Rupees. Guide to invest in Liquidia from India. Also see the sentimental analysis on Indian investors investing in Liquidia. Get details on the Indian mutual funds that are investing in Liquidia. Get Analyst recommendations and forecasts along with all the Liquidia's financials.

Liquidia share price movements

Today's Low: $11.32
Today's High: $11.66
$11.53
1.82%
Downside
Day's Volatility :2.92%
Upside
1.11%
52 Weeks Low: $8.26
52 Weeks High: $16.99
$11.53
28.36%
Downside
52 Weeks Volatility :51.38%
Upside
32.14%

Liquidia Returns

Period	Liquidia Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	13.71%	-9.0%	0.0%
6 Months	-6.87%	-4.6%	0.0%
1 Year	-5.41%	3.0%	0.0%
3 Years	145.32%	0.0%	-21.1%

Liquidia Key Statistics

in dollars & INR

Previous Close	$11.44
Open	$11.48
Today's High	$11.66
Today's Low	$11.32
Market Capitalization	$975.9M
Today's Volume	$340.6K
52 Week High	$16.99
52 Week Low	$8.26
Revenue TTM	$14.8M
EBITDA	$-95.8M
Earnings Per Share (EPS)	$-1.62
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-181.73%

How to invest in Liquidia from India?

It is very easy for Indian residents to invest directly in Liquidia from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Liquidia stock in both Indian Rupees (INR) and US Dollars (USD). Search for Liquidia or LQDA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Liquidia or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Liquidia shares which would translate to 0.074 fractional shares of Liquidia as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Liquidia, in just a few clicks!

Returns in Liquidia for Indian investors in Rupees

Investment Value

₹1,00,000

Liquidia investment value today

Current value as on today

₹96,824

Returns

₹3,176

(-3.18%)

Returns from Liquidia Stock

₹5,414 (-5.41%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Liquidia

229%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Liquidia on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 229% more investors are searching Liquidia in the last 30 days versus the previous period.

Global Institutional Holdings in Liquidia

Caligan Partners LP
9.59%
Patient Square Capital
8.49%
BlackRock Inc
5.01%
Vanguard Group Inc
4.07%
Farallon Capital Management, L.L.C.
3.89%
Findell Capital Management LLC
3.77%

Analyst Recommendation on Liquidia

Buy

84%Buy

7%Hold

7%Sell

Based on 13 Wall street analysts offering stock ratings for Liquidia(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Liquidia

What analysts predicted

Upside of 119.43%

Current:

$11.53

Target:

$25.30

Insights on Liquidia

Price Movement
In the last 7 days, LQDA stock has moved up by 8.9%
Increasing Revenue
Revenue is up for the last 3 quarters, 2.97M → 4.44M (in $), with an average increase of 18.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -40.92M → -23.15M (in $), with an average increase of 33.6% per quarter
LQDA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 28.0%
Price to Sales
ForLQDA every $1 of sales, investors are willing to pay $54.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Liquidia Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$2.7M	↓ 62.7%
Net Income	$-53.1M	↑ 82.26%
Net Profit Margin	-2.0K%	↓ 1561.24%

	FY19	Y/Y Change
Revenue	$8.1M	↑ 198.2%
Net Income	$-46.4M	↓ 12.7%
Net Profit Margin	-574.69%	↑ 1388.23%

	FY20	Y/Y Change
Revenue	$739.6K	↓ 90.84%
Net Income	$-57.5M	↑ 23.93%
Net Profit Margin	-7.8K%	↓ 7198.3%

	FY21	Y/Y Change
Revenue	$12.9M	↑ 1637.81%
Net Income	$-29.8M	↓ 48.2%
Net Profit Margin	-231.7%	↑ 7541.29%

	FY22	Y/Y Change
Revenue	$15.9M	↑ 23.98%
Net Income	$-38.4M	↑ 28.82%
Net Profit Margin	-240.76%	↓ 9.06%

	FY23	Y/Y Change
Revenue	$17.5M	↑ 9.75%
Net Income	$-78.5M	↑ 104.62%
Net Profit Margin	-448.89%	↓ 208.13%

	Q2 FY23	Q/Q Change
Revenue	$4.8M	↑ 6.52%
Net Income	$-23.5M	↑ 79.05%
Net Profit Margin	-491.37%	↓ 199.05%

	Q3 FY23	Q/Q Change
Revenue	$3.7M	↓ 23.15%
Net Income	$-15.8M	↓ 32.86%
Net Profit Margin	-429.31%	↑ 62.06%

	Q4 FY23	Q/Q Change
Revenue	$4.5M	↑ 23.19%
Net Income	$-27.5M	↑ 73.84%
Net Profit Margin	-605.83%	↓ 176.52%

	Q1 FY24	Q/Q Change
Revenue	$3.0M	↓ 34.41%
Net Income	$-40.9M	↑ 49.1%
Net Profit Margin	-1.4K%	↓ 771.29%

	Q2 FY24	Q/Q Change
Revenue	$3.7M	↑ 23.12%
Net Income	$-27.9M	↓ 31.73%
Net Profit Margin	-763.65%	↑ 613.47%

	Q3 FY24	Q/Q Change
Revenue	$4.4M	↑ 21.56%
Net Income	$-23.2M	↓ 17.13%
Net Profit Margin	-520.57%	↑ 243.08%

	FY18	Y/Y Change
Profit	$2.6M	↓ 62.73%

	FY19	Y/Y Change
Profit	$7.3M	↑ 180.98%

	FY20	Y/Y Change
Profit	$501.9K	↓ 93.09%

	FY21	Y/Y Change
Profit	$9.8M	↑ 1858.58%

	FY22	Y/Y Change
Profit	$13.1M	↑ 33.02%

	FY23	Y/Y Change
Profit	$14.6M	↑ 11.65%

	Q2 FY23	Q/Q Change
Profit	$4.1M	↑ 7.19%

	Q3 FY23	Q/Q Change
Profit	$3.1M	↓ 24.47%

	Q4 FY23	Q/Q Change
Profit	$3.3M	↑ 4.89%

	Q1 FY24	Q/Q Change
Profit	$1.2M	↓ 62.7%

	Q2 FY24	Q/Q Change
Profit	$2.2M	↑ 78.13%

	Q3 FY24	Q/Q Change
Profit	$2.9M	↑ 33.1%

	FY18	Y/Y Change
Operating Cash Flow	$-31.8M	↑ 31.04%
Investing Cash Flow	$-870.9K	↓ 65.77%
Financing Cash Flow	$68.8M	↑ 138.83%

	FY19	Y/Y Change
Operating Cash Flow	$-48.3M	↑ 51.69%
Investing Cash Flow	$-1.9M	↑ 112.42%
Financing Cash Flow	$66.4M	↓ 3.52%

	FY20	Y/Y Change
Operating Cash Flow	$-54.1M	↑ 12.14%
Investing Cash Flow	$247.9K	↓ 113.4%
Financing Cash Flow	$63.4M	↓ 4.48%

	FY21	Y/Y Change
Operating Cash Flow	$-34.0M	↓ 37.14%
Investing Cash Flow	$-107.2K	↓ 143.25%
Financing Cash Flow	$26.3M	↓ 58.5%

	FY22	Y/Y Change
Operating Cash Flow	$-28.6M	↓ 16.01%
Investing Cash Flow	$-587.0K	↑ 447.47%
Financing Cash Flow	$65.0M	↑ 146.82%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-5.6M	↓ 34.21%
Investing Cash Flow	$-243.0K	↑ 0.0%
Financing Cash Flow	$-409.0K	↓ 104.11%

Liquidia Technicals Summary

Sell

Neutral

Buy

Liquidia is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Liquidia Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Liquidia Corp	0.96%	-6.87%	-5.41%	145.32%	145.32%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Liquidia Corp	NA	NA	NA	-1.63	-1.82	-0.41	NA	0.69
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Liquidia Corp	Buy	$975.9M	145.32%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Liquidia

liquidia technologies is a biopharmaceutical company transforming the development of new therapies by precisely engineering drug particles. our proprietary print technology is a simple, elegant solution that solves common problems with drug delivery and efficacy. print technology is a scalable cgmp compliant process that creates particles and can apply to virtually any therapeutic area, molecule or route of administration. liquidia is bringing more efficient, controlled development capabilities to the industry while enhancing the safety and quality of products for patients. liquidia is advancing product candidates from its own pipeline. these initial product candidates, liq861 and liq865, apply the print technology to better drug delivery in inhaled and pain therapeutic areas, respectively. the print technology is also licensed with world-leading pharmaceutical companies that are developing future product candidates.

Organization	Liquidia
Employees	145
CEO	Dr. Roger A. Jeffs Ph.D.
Industry	Health Technology

Management People of Liquidia

Name	Title
Dr. Roger A. Jeffs Ph.D.	CEO & Director
Mr. Michael Kaseta	COO & CFO
Mr. Russell Schundler	General Counsel & Corporate Secretary
Mr. William R. Kenan Jr.	Co-Founder
Dr. Ginger Denison	Co-Founder
Ms. Sarah Krepp SPHR	Vice President of People & Culture
Mr. Jason Adair	Chief Business Officer
Mr. Scott Moomaw	Chief Commercial Officer
Dr. Rajeev Saggar M.D.	Chief Medical Officer
Mr. Michael Hunter	Senior Vice President of Manufacturing Operations

Important FAQs about investing in Liquidia from India :

What is Liquidia share price today?

Liquidia share price today stands at $11.53, Open: $11.48 ; Previous Close: $11.44 ; High: $11.66 ; Low: $11.32 ; 52 Week High: $16.99 ; 52 Week Low: $8.26. The stock opens at $11.48, after a previous close of $11.44. The stock reached a daily high of $11.66 and a low of $11.32, with a 52-week high of $16.99 and a 52-week low of $8.26.

Can Indians buy Liquidia shares?

Yes, Indians can invest in the Liquidia (LQDA) from India.

With INDmoney, you can buy Liquidia at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Liquidia at zero transaction cost.

How can I buy Liquidia shares from India?

It is very easy to buy Liquidia from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Liquidia be purchased?

Yes, you can buy fractional shares of Liquidia with INDmoney app.

What are the documents required to start investing in Liquidia stocks?

To start investing in Liquidia, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.